Halozyme Therapeutics

IPO

Reinventing the patient experience. | Halozyme

Public · San Diego, United States · Founded 1998 · $13.9M raised

Employees
501–1000
Founded
1998
Business Model
B2B
Total Funding
$13.9M
Last Round
$13.9M Corporate RoundOct 2004
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Halozyme Therapeutics is a biopharmaceutical company developing proprietary drug delivery technology (ENHANZE) to improve patient experience and treatment outcomes.

Summary

Halozyme Therapeutics is a Biotech company based in San Diego, United States, founded in 1998. It has raised $13.9M in total across 1 round, most recently a $13.9M Corporate Round in Oct 2004.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Secondary MarketSecondary Market2012 (est.)

Sign up to see all 5 events

Funding: Corporate Round. Amounts, valuations, and investors where available.

Acquisitions

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Halozyme Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/halozyme-therapeutics"><img src="https://indexed.vc/api/badge/company/halozyme-therapeutics" alt="Halozyme Therapeutics on Indexed.vc" width="260" height="76" /></a>